Position emission tomography (PET) offers the possibility of measuring noninvasively regional myocardial blood flow, substrate fluxes and biochemical reaction rates in the human heart. A multitude of positron emitting tracers is available. Studies with PET and radiotracers in animals and in humans have been encouraging and appear to have direct clinical impact. However, PET studies have remained largely qualitative. The metabolism of radiotracers and the fate of the label in myocardium as reflected by rates of tracer tissue uptake and clearance needs to be defined and its relationship to the physiologic process as for example blood flow, oxygen, glucose and fatty acid metabolism and TCA cycle activity firmly established so that tracer kinetic models can be validated or newly developed. Through these tracer kinetic models operational equations are derived which then quantify regional functional processes in the human heart in ml or mmol/min/gram myocardium. The research seeks to continue development and/or validation of PET measurement techniques, specifically of glucose, fatty acid, oxygen and TCA cycle metabolism and blood flow. It also seeks to clarify mechanisms and pathophysiology of PET observations in human myocracial ischemia. The proposed studies will largely be performed in acute or chronic dog experiments, including biochemical assays of myocardial tissue and blood, tissue histology and autoradiography. Once vailidated in animals, these techniques will then be tested in human subjects. The proposed research forms the basis for developing PET into a tool for studying the human heart's normal and abnormal physiology. With this tool then, mechanisms of disease can be examined and the severity of the disease process determined. This will directly impact detection and treatment of human cardiac disease, design of new therapeutic strategies and monitoring effects of therapy.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL029845-05
Application #
3340903
Study Section
Diagnostic Radiology Study Section (RNM)
Project Start
1983-07-01
Project End
1991-06-30
Budget Start
1987-07-01
Budget End
1988-06-30
Support Year
5
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Organized Research Units
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Kofoed, K F; Schoder, H; Knight, R J et al. (2000) Glucose metabolism in reperfused myocardium measured by [2-18F] 2-fluorodeoxyglucose and PET. Cardiovasc Res 45:321-9
Porenta, G; Cherry, S; Czernin, J et al. (1999) Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging. Eur J Nucl Med 26:1465-74
Sun, K T; Yeatman, L A; Buxton, D B et al. (1998) Simultaneous measurement of myocardial oxygen consumption and blood flow using [1-carbon-11]acetate. J Nucl Med 39:272-80
Schelbert, H R (1998) Measurements of myocardial metabolism in patients with ischemic heart disease. Am J Cardiol 82:61K-67K
Sun, K T; Chen, K; Huang, S C et al. (1997) Compartment model for measuring myocardial oxygen consumption using [1-11C]acetate. J Nucl Med 38:459-66
Bottcher, M; Czernin, J; Sun, K et al. (1997) Effect of beta 1 adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity. J Nucl Med 38:442-6
Nitzsche, E U; Choi, Y; Czernin, J et al. (1996) Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques. Circulation 93:2000-6
Nagamachi, S; Czernin, J; Kim, A S et al. (1996) Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. J Nucl Med 37:1626-31
Weismuller, S; Czernin, J; Sun, K T et al. (1996) Coronary vasodilatory capacity is impaired in patients with dilated cardiomyopathy. Am J Card Imaging 10:154-62
Sun, K T; Czernin, J; Krivokapich, J et al. (1996) Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation 94:3146-54

Showing the most recent 10 out of 114 publications